News It was reported in The Edge Financial
Daily that TSH had only received a 8.2% acceptance rate so far from the
shareholders of Pontian.
For the deal to go through, TSH and the other joint offerors
need a marginal acceptance of 30.28%, and hence it will still need another 22%
acceptance rate (after the above).
Recall that TSH and the other joint offerors already own
19.72% of Pontian.
Comments We believe that the deal is unlikely
to go through, judging from the Bursa announcement that the “Final Closing
Date” for the offer is 10-Sep (today).
After the closing date, TSH could either offer higher prices
for Pontian shares (above RM90) or leave the offer lapsed. In our view, TSH is
unlikely to offer better prices as this will push its net gearing above 0.85x.
Outlook Despite this negative news
flow, the company’s healthy fundamentals with a strong FY12-13E FFB growth rate
of 12%-30% is unaffected.
The long term outlook remains positive as we believe that
TSH can sustain a 5-year FFB CAGR growth of 16% as its Kalimantan estates
mature.
Hence, we believe that any share price weakness will be good
opportunity to accumulate TSH shares at more attractive levels.
Forecast Our FY12-13E earnings forecasts
of RM112m-RM149m are unchanged as we did not factor in anycontributions from
Pontian previously.
Our key assumptions are FY12-13E CPO prices of RM3150-RM3100
and FFB productions of 448k-583k.
Rating Maintain
OUTPERFORM
We continue to like TSH for its young age profile of around
6.2 years old, which is the youngest for planters under our coverage.
Valuation Maintaining our TP of RM2.85 based
on FY13E PER of 15.8x (+1SD@5-year mean, implying a premium to its peers which
only command +0.5SD for the reasons given above).
Risks A sustained drop in CPO prices.
Source: Kenanga
No comments:
Post a Comment